the aid library

LIST OPTIONS

Filter

6081

Films about coronavirus (COVID-19)

Picturing Health (2020) CC

Here you can download animations about COVID-19 for information, community organising, broadcast or whatsapp groups in multiple languages for Africa and Asia. All about COVID-19: Advice for Communities. What is coronavirus? How does it spread? How does hand washing and physical distancing help? Wha... more

External Link

Ebola

WiRed International (2014)

Ebola online Training cours in French It is important for all people in regions threatened by Ebola to understand basic issues related to the disease. This module offers non-professionals a useful overview of Ebola, including how people contract Ebola, who is at highest risk and the signs and sympt... more

Download (406)

View PDF (189)

National Monkeypox Public Health Response Guidelines

Federal Ministry of Health - Nigeria Centre for Disease Control (2019) CC

Since the re-emergence of monkeypox in Nigeria in September 2017, the Nigeria Centre for Disease Control(NCDC) has continued to receive reports and respond to cases of the disease from States across the country. Between September 2017 when the outbreak started and November 2018, about 300 suspecte... more

Download (227)

View PDF (258)

Cognitive Training for Schizophrenia in Developing Countries: A Pilot Trial in Brazil (Clinical Study)

Pontes LM, Martins CB, Napolitano IC, Fonseca JR, Oliveira GM, Iso SM, Menezes AK, Vizzotto AD, di Sarno ES, Elkis H. Schizophrenia Research and Treatment (2013) CC

Cognitive deficits in schizophrenia can massively impact functionality and quality of life, furthering the importance of cognitive training. Despite the development of the field in Europe and in the United States, no programmes have been developed and tested in developing countries. Different cultur... more

Download (573)

View PDF (605)

Integrating neglected tropical diseases in global health and development: fourth WHO report on neglected tropical diseases

World Health Organization (WHO) (2017) C_WHO

Advances have been made through expanded interventions delivered through five public health approaches: innovative and intensified disease management; preventive chemotherapy; vector ecology and management; veterinary public health services; and the provision of safe water, sanitation and hygiene. I... more

External Link

مواد موارد الكوليرا

UN Children's Fund UNICEF (2022) C_UNICEF

The UNICEF Syria webpage titled "Cholera Resource Material" offers a collection of educational resources aimed at preventing cholera and safeguarding families. These materials, available in Arabic, include posters and flyers on topics such as handwashing, water purification, recognizing cholera symp... more

Download (59)

View PDF (64)

Chronic Respiratory Disease - Asbestosis

Hall A.G. Mediclinic Southern Africa (2008) CC2

The webpage provides detailed information about asbestosis, a lung disease caused by inhaling asbestos fibers. It outlines various asbestos-related diseases, including benign and malignant pleural conditions as well as lung cancer. Asbestosis is described as a diffuse fibrotic disease of lung tissue... more

Download (112)

View PDF (146)

Action Protocol for Enhanced SARI and ILI Surveillance for COVID-19 in Africa (Arabic)

African Union; Africa CDC Centres for Disease Control and Prevention (2020) C2

March 2020 The number of African Union Member States reporting COVID- 19 cases is increasing and there is a likelihood of community transmission. The WHO recently modified the COVID-19 suspect case definition to include severe acute respiratory infection and advises testing of all severe acute r... more

Download (182)

View PDF (239)

Providing mental health first aid to a co-worker. Mental Health first aid guidelines

MHFA MHFA (2010) CC

Work can be beneficial or harmful to mental health depending on the circumstances. If a person has a mental health problem, being at work in a supportive workplace can assist in their recovery. The level of support needed will fluctuate, as the symptoms of most mental health problems come and go... more

Download (75)

View PDF (64)

Occupational Lung Diseases - What are work-related lung diseases?

Cedars-Sinai Cedars-Sinai (2023) CC2

The Cedars-Sinai webpage on occupational lung diseases provides an overview of various lung conditions caused by exposure to harmful substances in the workplace. It outlines common types of occupational lung diseases, including asbestosis, silicosis, coal workers’ pneumoconiosis, and chemical-rela... more

Download (162)

View PDF (219)

Learn more about monkeypox as we record first confirmed case in SA

Saphra (2022) CC

South Africa has recorded its first case of monkeypox today, 23 June 2022. The Minister of Health Dr. Joe Phaahla explained that he received a report from the National Health Laboratory Services’ CEO that they have confirmed through laboratory tests the first case of monkeypox in South Africa. ... more

External Link

Video: Is your child sick?/JE, MTOTO WAKO NI MGONJWA?

Medical Aid Films (2015) C1

JE, MTOTO WAKO NI MGONJWA? MUDA MREFU FILAMU - KUHARISHA, NYUMONIA, MALARIA This film is the full length version of the Is Your Child Sick? videos on pneumonia, diarrhoea and malaria. The film is aimed at community health workers, parents and communities to teach them the important signs and symp... more

Download (59)

View PDF (59)

Occupational Lung Diseases

John Hopkins Medicine Johns Hopkins Medicine (2024) CC2

The Johns Hopkins Medicine webpage on occupational lung diseases provides an overview of lung conditions caused by exposure to harmful substances in the workplace. It explains various types of occupational lung diseases, including asbestosis, silicosis, coal workers' pneumoconiosis, and hypersensiti... more

Download (119)

View PDF (63)

Type II Diabetes Poster

Wallace, L. SlideShare (2016) CC2

Type 2 diabetes mellitus (T2DM) is a chronic condition characterized by insulin resistance and an inability to properly regulate blood sugar levels. The two most important risk factors for T2DM are a family history of diabetes and obesity, though age, race, diet, and exercise level also impact risk.... more

External Link

Cholera. Key facts

World Health Organization (WHO) (2022) C_WHO

The World Health Organization's cholera fact sheet provides essential information about cholera, an acute diarrheal infection caused by ingesting food or water contaminated with Vibrio cholerae bacteria. The disease remains a global public health threat, particularly in areas lacking safe water and ... more

External Link (203)

Dengue

MSD Manual (2023) C2

Dengue is a mosquito-borne disease caused by a flavivirus. Dengue fever usually results in abrupt onset of high fever, headache, myalgias, arthralgias, and generalized lymphadenopathy, followed by a rash that appears with a recurrent fever after an afebrile period. Respiratory symptoms, such as coug... more

Download (124)

View PDF (159)

Immunization in the context of COVID-19 pandemic: frequently asked questions (‎‎‎‎FAQ)‎‎‎‎, 16 April 2020. Arabic Version

World Health Organization WHO; UNICEF (2020) C_WHO

Immunizations are an essential health service that protect susceptible individuals from vaccine-preventable diseases (VPD).2 By providing timely immunizations, individuals and communities remain protected and the likelihood of a VPD outbreak decreases, Preventing a VPD ... more

External Link

External Link (113)

Malaria - WHO

World Health Organisation (WHO) (2025) C_WHO

The World Health Organization's malaria fact sheet provides an overview of malaria, a life-threatening disease caused by Plasmodium parasites transmitted through the bites of infected female Anopheles mosquitoes. It highlights that malaria is preventable and curable, yet remains a significant glo... more

External Link

Effect of COVID-19 pandemic on provision of sexual and reproductive health services in primary health facilities in Nigeria: a cross-sectional study

Adelekan, B.; E. Goldson, Z. Abubakar et al. Repoductive Health Journal (2021) CC

RESULTS: Between 76 and 97% of the PHCS offered RMCAH services before the lockdown. Except in antenatal, delivery and adolescent care, there was a decline of between 2 and 6% in all the services during the lockdown and up to 10% decline after the lockdown with variation across and within States. Dur... more

Download (345)

View PDF (456)

Therapeutics and COVID-19 (Living Guideline, 10 November 2023)

World Health Organization WHO (2023) C_WHO

WHO has updated its guidelines for COVID-19 therapeutics, with revised recommendations for patients with non-severe COVID-19. This is the 13th update to these guidelines. Updated risk rates for hospital admission in patients with non-severe COVID-19 The guidance includes updated risk rates for... hospital admission in patients with non-severe COVID-19. The current COVID-19 virus variants tend to cause less severe disease while immunity levels are higher due to vaccination, leading to lower risks of severe illness and death for most patients. This update includes new baseline risk estimates for hospital admission in patients with non-severe COVID-19. The new ‘moderate risk’ category now includes people previously considered to be high risk including older people and/or those with chronic conditions, disabilities, and comorbidities of chronic disease. The updated risk estimates will assist healthcare professionals to identify individuals at high, moderate or low risk of hospital admission, and to tailor treatment according to WHO guidelines: **High: **People who are immunosuppressed remain at higher risk if they contract COVID-19, with an estimated hospitalization rate of 6%. **Moderate: **People over 65 years old, those with conditions like obesity, diabetes and/or chronic conditions including chronic obstructive pulmonary disease, kidney or liver disease, cancer, people with disabilities and those with comorbidities of chronic disease are at moderate risk, with an estimated hospitalization rate of 3%. Low: Those who are not in the high or moderate risk categories are at low risk of hospitalization (0.5%). Most people are low risk. Review of COVID-19 treatments for people with non-severe COVID-19 WHO continues to strongly recommend nirmatrelvir-ritonavir (also known by its brand name ‘Paxlovid’) for people at high-risk and moderate risk of hospitalization. The recommendations state that nirmatrelvir-ritonavir is considered the best choice for most eligible patients, given its therapeutic benefits, ease of administration and fewer concerns about potential harms. Nirmatrelvir-ritonavir was first recommended by WHO in April 2022. If nirmatrelvir-ritonavir is not available to patients at high-risk of hospitalization, WHO suggests the use of molnupiravir or remdesivir instead. WHO suggests against the use of molnupiravir and remdesivir for patients at moderate risk, judging the potential harms to outweigh the limited benefits in patients at moderate risk of hospital admission. For people at low risk of hospitalization, WHO does not recommend any antiviral therapy. Symptoms like fever and pain can continue to be managed with analgesics like paracetamol. WHO also recommends against use of a new antiviral (VV116) for patients, except in clinical trials. The update also includes a strong recommendation against the use of ivermectin for patients with non-severe COVID-19. WHO continues to advise that in patients with severe or critical COVID-19, ivermectin should only be used in clinical trials. more